Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Kymera Therapeutics (KYMR) stock falls today as biotech slips — what traders are watching

Shares of Kymera Therapeutics fell about 3% to $77.94 in afternoon trading on Tuesday, lagging a broader biotech dip. The SPDR S&P Biotech ETF was down about 1.4%, while the iShares Nasdaq Biotechnology ETF slipped about 1.1%.

30 December 2025

Biotechnology·NASDAQ:KYMR·Stock Market

Almonty Industries stock today: ALM slips as CBS report spotlights U.S. tungsten supply deal

Shares of Almonty Industries Inc fell about 3.9% to $8.90 in afternoon trading on Tuesday after giving up an early rise, with the stock swinging between $8.90 and $9.39.

30 December 2025

Mining Industry·Stock Market·TSX:ALM·US Economy

Why Praxis Precision Medicines (PRAX) stock is down today after FDA breakthrough nod for its tremor drug

Shares of Praxis Precision Medicines Inc slipped about 3% on Tuesday, giving back part of a sharp rally sparked by an FDA regulatory boost for its lead essential tremor program. The stock was down 3% at $295.50 as of 2:39 p.m. ET, after opening at $304.00 and trading between $286.58 and $304.70.

30 December 2025

Healthcare Innovation·NASDAQ:PRAX·Pharmaceutical Industry

Why Caris Life Sciences (CAI) stock is down today as biotech slips

Caris Life Sciences shares were down about 1.8% at $27.44 as of 2:41 p.m. ET, after trading between $27.00 and $27.97 during Tuesday’s session.

30 December 2025

NASDAQ:CAI

Why Cogent Biosciences stock is down today after its FDA filing for bezuclastinib

Shares of Cogent Biosciences, Inc. fell 2.7% to $36.88 on Tuesday after the biotech said it submitted a New Drug Application to the U.S. Food and Drug Administration for its drug candidate bezuclastinib in nonadvanced systemic mastocytosis. Yahoo Finance

30 December 2025

NASDAQ:COGT·Pharmaceuticals·Stock Market

Arcutis Biotherapeutics stock slides today as biotech pulls back, ARQT down nearly 3%

Arcutis Biotherapeutics shares fell 2.9% to $27.74 in afternoon trading on Tuesday, after moving between $27.72 and $28.65. Volume was about 0.6 million shares.

30 December 2025

NASDAQ:ARQT·Stock Market

Vera Therapeutics stock drops 3% today as biotech slips into year-end trading

Vera Therapeutics, Inc. shares slid 3.4% to $50.45 in afternoon trading on Tuesday, giving back some recent gains as biotech stocks softened late in the year.

30 December 2025

NASDAQ:TVTX·NASDAQ:VERA·Stock Market

Ares Management stock drops 3% in New York as Fed minutes hit year-end trading

Shares of Ares Management Corp fell 3.1% to $163.85 in afternoon trading on Tuesday, down $5.20 from Monday’s close. The stock traded between $168.99 and $163.49, with about 966,000 shares changing hands.

30 December 2025

Federal Reserve·NYSE:ARES·Stock Market

Soleno Therapeutics stock slides today: SLNO drops on investor-alert headline as biotech sector slips

Shares of Soleno Therapeutics, Inc. fell 3.1% to $46.09 in afternoon trading on Tuesday, after a law firm said it was investigating potential claims on behalf of investors. The drop outpaced declines in biotech benchmarks, with the SPDR S&P Biotech ETF down about 1.4% and the iShares Nasdaq Biotechnology ETF off about 1.1%.

30 December 2025

NASDAQ:SLNO

Why Karman Holdings Stock Is Down Today: KRMN Slides as Year-End Flows Hit Defense-Space Names

Karman Holdings Inc. shares were down 3.6% at $74.81 in afternoon trading on Tuesday, after touching $74.21 at the session low. The stock traded as high as $78.55, with about 465,000 shares changing hands.

30 December 2025

Defense Industry·NASDAQ:KRMN·Stock Market

Zenas BioPharma stock slides 5% today as biotech shares sag; Phase 3 INDIGO data in focus

Zenas BioPharma Inc shares fell $2.02, or 5.2%, to $37.03 in afternoon trading on Tuesday, after ending the prior session at $39.05. The stock ranged from $36.94 to $40.50, with about 123,000 shares traded.

30 December 2025

NASDAQ:RPRX·NASDAQ:ZBIO·Stock Market

BETA Technologies stock slides in year-end trade: what’s driving the move and what investors watch next

Shares of BETA Technologies, Inc. fell 3.4% to $28.46 in afternoon trading on Tuesday after opening at $29.82, leaving the stock near the day’s low of $28.37. The session high was $29.79, with about 304,000 shares traded.

30 December 2025

NYSE:BETA·Stock Market

Arrowhead Pharmaceuticals stock slides today as biotech dips; ARWR investors eye January obesity data

Arrowhead Pharmaceuticals Inc shares were down 3.6% at $67.09 at 1:47 p.m. ET on Tuesday, after trading between $65.94 and $69.95.

30 December 2025

NASDAQ:ARWR·Pharmaceuticals·Stock Market

Freshpet stock slides as Fed minutes loom in thin year-end trade (FRPT)

Freshpet, Inc. shares were down 3.5% at $60.84 by 1:59 p.m. ET on Tuesday, extending a choppy stretch for the pet food maker’s stock.

30 December 2025

Federal Reserve·NASDAQ:FRPT·Stock Market

GMAB stock slides as Genmab scraps late-stage acasunlimab cancer therapy

Genmab A/S’s U.S.-listed shares fell 3.3% to $31.45 in Tuesday’s regular session. The stock traded between $31.40 and $32.06 after opening at $31.98, with about 1.9 million shares changing hands.

30 December 2025

NASDAQ:GMAB·Pharmaceutical Industry·Stock Market

Lionsgate Studios (LION) stock slides today after insider sales hit the tape

Lionsgate Studios Corp shares fell 3.4% on Tuesday, retreating after filings showed two top executives sold stock late this month. The stock was down 32.5 cents at $9.105, after trading between $9.06 and $9.45.

30 December 2025

NYSE:LION·Stock Market

Energy Fuels stock falls today as UUUU pulls back after uranium sales beat, new contracts

Shares of Energy Fuels Inc fell 3.5% to $14.55 in afternoon trading on Tuesday. The uranium miner lagged peers, with Uranium Energy down about 1.9% while Cameco was little changed and MP Materials slipped about 1.3%. Energy Fuels traded about 5.9 million shares and ranged between $14.30 and $15.28.

30 December 2025

AMEX:UUUU·Energy Sector·Stock Market

ADMA Biologics stock slides nearly 4% as biotech weakens in thin year-end trade

Shares of ADMA Biologics fell 3.7% to $18.40 in afternoon trading on Tuesday, a steeper drop than the broader biotech group. The SPDR S&P Biotech ETF was down about 1.3%.

30 December 2025

NASDAQ:ADMA·Stock Market

Rivian stock drops nearly 6% as CEO share-sale filing hits the tape in thin year-end trade

Rivian Automotive, Inc shares were down about 6% on Tuesday, pulling back in a light year-end session after a regulatory filing disclosed a stock sale by Chief Executive Officer Robert J. Scaringe.

30 December 2025

Electric Vehicles·NASDAQ:RIVN·NASDAQ:TSLA·Stock Market

Mineralys Therapeutics (MLYS) stock slides today as biotech weakens; FDA filing timeline in focus

Shares of Mineralys Therapeutics Inc fell 3.3% to $35.61 by early afternoon on Tuesday, after touching a session low of $35.17. About 513,000 shares had changed hands, versus a previous close of $36.83.

30 December 2025

NASDAQ:MLYS·Pharmaceutical Industry·Stock Market

Previous 1 … 362 363 364 365 366 … 609 Next

#1 STRONG BUY

Xylem

NYSE: XYL 95 / 100

#2 BUY

AerCap

NYSE: AER 93 / 100

#3 BUY ON WEAKNESS

Visa

NYSE: V 90 / 100

#4 TACTICAL BUY

Chevron

NYSE: CVX 87 / 100

#5 ACCUMULATE

UPS

NYSE: UPS 84 / 100

View full portfolio

Shan Ahmed Khan

Kymera Therapeutics (KYMR) stock falls today as biotech slips — what traders are watching

Almonty Industries stock today: ALM slips as CBS report spotlights U.S. tungsten supply deal

Why Praxis Precision Medicines (PRAX) stock is down today after FDA breakthrough nod for its tremor drug

Why Caris Life Sciences (CAI) stock is down today as biotech slips

Why Cogent Biosciences stock is down today after its FDA filing for bezuclastinib

Arcutis Biotherapeutics stock slides today as biotech pulls back, ARQT down nearly 3%

Vera Therapeutics stock drops 3% today as biotech slips into year-end trading

Ares Management stock drops 3% in New York as Fed minutes hit year-end trading

Soleno Therapeutics stock slides today: SLNO drops on investor-alert headline as biotech sector slips

Why Karman Holdings Stock Is Down Today: KRMN Slides as Year-End Flows Hit Defense-Space Names

Zenas BioPharma stock slides 5% today as biotech shares sag; Phase 3 INDIGO data in focus

BETA Technologies stock slides in year-end trade: what’s driving the move and what investors watch next

Arrowhead Pharmaceuticals stock slides today as biotech dips; ARWR investors eye January obesity data

Freshpet stock slides as Fed minutes loom in thin year-end trade (FRPT)

GMAB stock slides as Genmab scraps late-stage acasunlimab cancer therapy

Lionsgate Studios (LION) stock slides today after insider sales hit the tape

Energy Fuels stock falls today as UUUU pulls back after uranium sales beat, new contracts

ADMA Biologics stock slides nearly 4% as biotech weakens in thin year-end trade

Rivian stock drops nearly 6% as CEO share-sale filing hits the tape in thin year-end trade

Mineralys Therapeutics (MLYS) stock slides today as biotech weakens; FDA filing timeline in focus

TechStock² Updates

Stock Market Today: Live Updates 02.08.2026

Student Loan Deal Worth $23 Billion Advances, With $12 Billion Distributed

MP Materials (NYSE:MP) heads into earnings with price support exceeding EBITDA as U.S. markets close for the weekend

Nu Holdings Ltd. (NYSE:NU) Confronts Credit Challenge as It Trails Regional Rivals

UiPath (NYSE:PATH) Shares Jump 18% After Buybacks Offset Weaker ARR Growth

Top Stock Picks

Xylem

AerCap

Visa

Chevron

UPS

Live updates

Investment Disclaimer